Condition
Prognostic Cancer Model clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Prognostic Cancer Model clinical trials that are recruiting, at sites in 2 countries (most in China (4), Czechia (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Prognostic Cancer Model clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus | — | Beijing, Beijing Municipality | Recruiting | Aug 12, 2025 |
| Analysis of colorectal cancer patients at Xijing Hospital since 2011 | — | Xi'an, Shaanxi | Recruiting | Mar 13, 2024 |
| AI system for diagnosing and predicting outcomes of breast phyllodes tumors | — | Guangzhou, Guangdong and 3 other locations | Recruiting | Feb 29, 2024 |
| Analyzing blood samples to understand Hodgkin lymphoma prognosis | — | Hradec Králové and 4 other locations | Recruiting | Feb 16, 2024 |
| Predicting disease-free survival in kidney cancer using deep learning and CT scans | — | Chongqing, Chongqing Municipality | Recruiting | Oct 18, 2023 |
All recruiting trials (5)
-
A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus
This project will test whether a new prediction model can guide treatment choices to improve survival for adults with renal cell carcinoma, including those with venous tumor thrombus.
-
Analysis of colorectal cancer patients at Xijing Hospital since 2011
This study looks at the different treatment methods and outcomes for colorectal cancer patients who had surgery at Xijing Hospital since 2011 to see how they compare.
-
AI system for diagnosing and predicting outcomes of breast phyllodes tumors
This study is testing whether an AI system can help doctors better diagnose and predict outcomes for patients with rare breast phyllodes tumors.
-
Analyzing blood samples to understand Hodgkin lymphoma prognosis
This study is trying to see if analyzing blood samples for certain mutations and the Epstein-Barr virus can help doctors better understand how Hodgkin lymphoma behaves and improve treatment decisions for patients.
-
Predicting disease-free survival in kidney cancer using deep learning and CT scans
This study is testing a new computer model that uses CT scans to see if it can help predict how long patients with localized kidney cancer will be free of disease after surgery.
Related topics
Quick answers
How many Prognostic Cancer Model clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.